Project Grant R01AG099081
- The National Institute on Aging awarded The Trustees of Columbia University in the City of New York $511,574 on July 1, 2026, under the Aging Research program (CFDA 93.866) to develop statistical methods for precision health management in high-risk Alzheimer's disease populations. The recipient will conduct three integrated research activities. Aim 1 involves evidence synthesis through semi-automated systematic review and meta-analyses of published studies to synthesize evidence on prognostic...
- The National Institute on Aging awarded Yale University $839,400 under the Aging Research program (CFDA 93.866) on September 1, 2026, to validate novel algorithms for assessing sleep deficiency in persons with Alzheimer's disease and related dementias. The project addresses the urgent need for feasible, accurate assessment methods for sleep deficiency in ADRD populations, where over half of patients experience sleep abnormalities that accelerate cognitive and functional decline. Existing...
- The National Institute on Aging awarded The Trustees of Columbia University in the City of New York $735,598 on July 15, 2026, under the Aging Research program (CFDA 93.866) to enhance research capacity for addressing Alzheimer's disease and related dementias and metal-induced cognitive decline in an aging cohort in Bangladesh. The award funds research investigating how chronic exposure to neurotoxic metal mixtures—including arsenic, lead, cadmium, manganese, and copper—influences cognitive...
- The National Institute on Aging awarded The Trustees of Columbia University in the City of New York $529,744 on February 15, 2026, under the Aging Research program (CFDA 93.866) to investigate the role of entorhinal cortex hyperactivity, neuroinflammation, and tau pathology progression in Alzheimer's disease. The research will use two-photon microscopy and chemogenetic manipulation to test three central hypotheses: that entorhinal cortex layer 2 neuronal hyperactivity drives disease...
- The National Institute on Aging awarded The Trustees of Columbia University in the City of New York $690,898 on September 15, 2026, under the Aging Research program (CFDA 93.866) to conduct functional genetic analyses of healthspan in humans. The recipient will identify shared genetic architecture underlying age-related diseases and aging-related traits, experimentally validate the regulatory roles of healthspan-associated non-coding variants and their target genes, and elucidate molecular...
- The National Institute on Aging awarded The Trustees of Columbia University in the City of New York $471,324 on September 1, 2026, under the Aging Research program (CFDA 93.866) to establish an integrated training program in data science and exposomics for Alzheimer's disease and related disorders (ADRD) research. The Columbia University Aging/ADRD, Exposomics and Data Sciences (AGEIS) training program integrates biostatistics, environmental health sciences, and lifecourse epidemiology across...
- The National Institute on Aging, part of the Department of Health and Human Services, awarded $132,300 to The Trustees of Columbia University in the City of New York on July 15, 2026, under the Aging Research program (CFDA 93.866) to examine the relationship between job loss due to layoffs across working years and the risk of Alzheimer's disease and related dementias in mid-to-later life. The research leverages longitudinal data from three complementary datasets spanning the working years of the...
- The National Institute on Aging awarded The Trustees of Columbia University in the City of New York $390,122 on March 15, 2026, under the Aging Research program (CFDA 93.866) to develop a novel group independent component analysis algorithm incorporating time-frequency information for longitudinal brain network analysis. The recipient will develop a group time-frequency independent component analysis (GTFICA) algorithm to capture temporal dynamics of functional brain networks in longitudinal...
- The National Institute on Aging awarded $1.9 million to The General Hospital Corporation (Massachusetts General Hospital) on March 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a multisite longitudinal cohort study examining sleep and circadian rhythm biomarkers in postoperative delirium and neurocognitive recovery. The study, titled Sleep and Circadian Rhythm Biomarkers of Postoperative Neurocognitive Recovery (SLEEP-POD2), will enroll 400 adults over age 65 undergoing...
- The National Institute on Aging awarded Weill Medical College of Cornell University $218,728 on March 3, 2026, under the Aging Research program (CFDA 93.866) to investigate vulnerable cell populations in aging-induced circadian clock remodeling and disruption. The recipient will conduct high-throughput single-nucleus RNA sequencing of flash-frozen tissues from young and aged mice sampled every four hours over two days in constant darkness. In the first aim, the investigator will profile seven...
The National Institute on Aging awarded The Trustees of Columbia University in the City of New York $697,394 on August 15, 2026, under the Aging Research program (CFDA 93.866) to develop and validate detailed quantification methods for 24-hour sleep and activity profiles from accelerometer data and to examine how modifiable activity behaviors affect Alzheimer's disease and related dementias outcomes. The project will establish approaches for robust, participant-level quantification of the full activity distribution from wearable accelerometer data; introduce methods for data-driven chronotype discovery and circadian rhythm analysis; and relate these nuanced phenotypes to cognitive health outcomes. The research addresses a gap in current practice: existing summary measures of physical activity are too narrow, and metrics quantifying activity timing and intensity lack consistency across studies, producing conflicting information and limiting public health insights. By leveraging intensive longitudinal accelerometer data, the project aims to develop metrics and phenotypes that provide actionable evidence on how complex features of activity timing, intensity, sleep, and circadian rhythmicity influence dementia risk. Performance takes place in New York, New York, with a period of performance from August 15, 2026, through May 31, 2031. Columbia's Health Sciences Division is the recipient and will conduct the work as a Project Grant, the standard assistance type under the Aging Research program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $697.4k | 8/13/26 |